The Latest in CLL

Isavuconazole resolved invasive fungal disease in patients on ibrutinib

July 29, 2018

Ibrutinib stacks up well on safety in pooled analysis

July 20, 2018

Ibrutinib/venetoclax shows early promise in relapsed CLL

July 11, 2018

Rapid venetoclax dose escalation aids relapsed CLL

July 5, 2018

Is CLL chemoimmunotherapy dead? Not yet

June 20, 2018

FDA grants regular approval to venetoclax for CLL/SLL

June 8, 2018

Venetoclax plus ibrutinib yields encouraging MRD results in first-line CLL

June 8, 2018

Older CLL and NHL patients are more vulnerable to toxicities

May 23, 2018

5-year data show deepening response with ibrutinib in CLL

May 11, 2018

Venetoclax shows muscle against CLL relapsed after idelalisib

April 18, 2018

Updated CLL guidelines incorporate a decade of advances

April 6, 2018

Experimental voxtalisib shows mixed results in phase 2 study

March 22, 2018

A global snapshot of leukemia incidence

March 13, 2018

Ibrutinib linked to invasive fungal infections

March 7, 2018

Baseline stress signals need for psychological help in CLL

February 23, 2018

CLL